$2.06
▼ -0.8% Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
Regentis Biomaterials Obtains Japanese Patent Allowance for Cartilage Repair Treatment
Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology
Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process
Overview
52-week range
$1.30
$8.35
11% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Implied volatility — last 90 days
No IV snapshots yet for RGNT.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.